Literature DB >> 300040

The effects of therapeutic irradiation on lymphocytes and immunity.

S E Order.   

Abstract

The lymphocytotoxic effect of therapeutic irradiation may lead to immune depression. The significance of such effects is yet to be determined in many malignancies, especially in light of the persistant immune depression in many "cured" patients. The present review examines the effects of age, type of cancer, and stage of disease as well as the results of immune parameters following radiation therapy. Factors to be considered in both the analysis of present day data and in future studies are also reviewed.

Entities:  

Mesh：

Year:  1977        PMID： 300040     DOI： 10.1002/1097-0142(197702)39:2+<737::aid-cncr2820390708>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  DNA Damage and Repair Biomarkers of Immunotherapy Response.

Authors:  Kent W Mouw; Michael S Goldberg; Panagiotis A Konstantinopoulos; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2017-06-19       Impact factor: 39.397

2.  Radiation and immunotherapy: a synergistic combination.

Authors:  Anusha Kalbasi; Carl H June; Naomi Haas; Neha Vapiwala
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

3.  Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer.

Authors:  Armin Jarosch; Ulrich Sommer; Andreas Bogner; Christoph Reißfelder; Jürgen Weitz; Mechthild Krause; Gunnar Folprecht; Gustavo B Baretton; Daniela E Aust
Journal:  Oncoimmunology       Date:  2017-11-07       Impact factor: 8.110

Review 4.  Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.

Authors:  Andrew B Sharabi; Phuoc T Tran; Michael Lim; Charles G Drake; Theodore L Deweese
Journal:  Oncology (Williston Park)       Date:  2015-05       Impact factor: 2.990

5.  Persistent changes in circulating white blood cell populations after splenectomy.

Authors:  Minke A E Rab; Aafke Meerveld-Eggink; Heleen van Velzen-Blad; Douwe van Loon; Ger T Rijkers; Okke de Weerdt
Journal:  Int J Hematol       Date:  2017-09-26       Impact factor: 2.490

6.  Tumour radiosensitivity is associated with immune activation in solid tumours.

Authors:  Tobin Strom; Louis B Harrison; Anna R Giuliano; Michael J Schell; Steven A Eschrich; Anders Berglund; William Fulp; Ram Thapa; Domenico Coppola; Sungjune Kim; Jessica Frakes; John Foekens; James J Mulé; Javier F Torres-Roca
Journal:  Eur J Cancer       Date:  2017-08-29       Impact factor: 9.162

Review 7.  Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

Authors:  Ravi B Patel; Claire C Baniel; Raghava N Sriramaneni; Kristin Bradley; Stephanie Markovina; Zachary S Morris
Journal:  Brachytherapy       Date:  2018-08-02       Impact factor: 2.362

8.  Immunological monitoring of patients affected by anaplastic glioma concerning in effects of surgery, radio-, and chemotherapy. A preliminary report.

Authors:  F Servadei; R Parente; F Spagnolli; G Gaist; R Padovani; M Bucci; L Steiner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.

Authors:  Feifei Teng; Dianbin Mu; Xiangjiao Meng; Li Kong; Hui Zhu; Sujing Liu; Jianbo Zhang; Jinming Yu
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

10.  Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.

Authors:  Jack M Qian; James B Yu; Harriet M Kluger; Veronica L S Chiang
Journal:  Cancer       Date:  2016-06-10       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.